Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I want to see the 10k ......
I want to see what the "noise" is about ......
The last 3 10ks came out beween the 11 - 17 ......
of the respective months .......
Last 10k showed a 26% revenue increase ......
DNAP has done alot since the last 10k filing .....
I want to see the DNAWITNESS numbers ......
I want to see the ANCESTRYBYDNA numbers .......
I want to see our BIOFANTRA numbers ......
I want to see things going forward ......
I WANT TO SEE : )s --- GEO
Anybody else notice .....
the charts are looking
GOOOOOOOOD --- GEO
jever00 ......
The only "news" I'm expecting .......
this month, is the .....
10K --- GEO
and some Co.s do it ........
Excellent Moral obligation ......
COVINGTON, La.--(BUSINESS WIRE)--Nov. 9, 2005--Phoenix Associates Land Syndicate (Pink Sheets:PBLS - News) announced today that the company is initiating a systematic share repurchase program to retire up to 100 million shares of the company's common stock to treasury. Effective immediately the company will begin repurchasing shares through both open-market and selected private transactions in order to reduce the total number of outstanding free-trading and restricted company securities.
Mr. Paul Alonzo, CEO of Phoenix, stated, "This initiative signifies the Company's commitment and unwavering focus to maximizing shareholder value. To date, we have been extremely reserved in share issuances and are now in the cash position to reward shareholders by actively repurchasing outstanding common stock to further propel the company's underlying fundamentals." He continued, "It is our plan to complete this stock repurchase in conjunction with the ongoing initiatives in place to facilitate fully-reporting status and an eventual exchange migration. We anticipate that we will be able to complete both initiatives by the end of the second quarter of next year."
IT CAN HAPPEN HERE AS WELL --- GEO
Golf4uto .....
It was either a big mistake .......
or else some on is trying to "screw" .....
with the graphs .......
PENNY STOCK TERRORISTS? --- GEO
golf4uto .......
You know it .....
I know it .......
others know it .....
It comes down to others wanting .......
TO SEE IT ON PAPER --- GEO
Here is the Bio deal ....
1.5mil Euros turns into 7.5mil Euros .....
up an additional 6% since Sept. 01 ......
The bonds began trading on the Frankfurt exchange on Wednesday, August 31, under the symbol (ISIN DE 000 A0E 964 9). If Biofrontera completes a public offering in the future, each purchaser in the offering at 100 euros can convert to 6.2 shares of Biofrontera stock. This conversion rate attributes a price of 16.13 euros per share to the Biofrontera common shares. If this accurately represents the fair market value of the Biofrontera common stock, then DNAPrint's 455,179 shares of Biofrontera stock, which it acquired for 1.5 million euros in July 2005, would now be valued at approximately 7.3 million euros.
``We believe our investment in Biofrontera will prove to be beneficial to DNAPrint genomics and to our shareholders,'' said DNAPrint genomics President and Chief Executive Officer Richard Gabriel. ``It validates our decision to build a collaborative relationship with Biofrontera in advance of its anticipated initial public offering.''
``Biofrontera is an excellent business partner for us because of its drug-product pipeline,'' said Hector J. Gomez, Ph.D., Chairman and Chief Medical Officer at DNAPrint genomics. ``We are pleased with our relationship with Biofrontera, and we have the highest confidence in its management team. We are confident the new funding will assist Biofrontera in advancing its drugs into the market.''
Mr. Gabriel and Dr. Gomez both are members of Biofrontera's Board of Directors.
The bonds began trading on the Frankfurt exchange on Wednesday, August 31, under the symbol (ISIN DE 000 A0E 964 9). If Biofrontera completes a public offering in the future, each purchaser in the offering at 100 euros can convert to 6.2 shares of Biofrontera stock. This conversion rate attributes a price of 16.13 euros per share to the Biofrontera common shares. If this accurately represents the fair market value of the Biofrontera common stock, then DNAPrint's 455,179 shares of Biofrontera stock, which it acquired for 1.5 million euros in July 2005, would now be valued at approximately 7.3 million euros.
``We believe our investment in Biofrontera will prove to be beneficial to DNAPrint genomics and to our shareholders,'' said DNAPrint genomics President and Chief Executive Officer Richard Gabriel. ``It validates our decision to build a collaborative relationship with Biofrontera in advance of its anticipated initial public offering.''
``Biofrontera is an excellent business partner for us because of its drug-product pipeline,'' said Hector J. Gomez, Ph.D., Chairman and Chief Medical Officer at DNAPrint genomics. ``We are pleased with our relationship with Biofrontera, and we have the highest confidence in its management team. We are confident the new funding will assist Biofrontera in advancing its drugs into the market.''
Mr. Gabriel and Dr. Gomez both are members of Biofrontera's Board of Directors.
The bonds began trading on the Frankfurt exchange on Wednesday, August 31, under the symbol (ISIN DE 000 A0E 964 9). If Biofrontera completes a public offering in the future, each purchaser in the offering at 100 euros can convert to 6.2 shares of Biofrontera stock. This conversion rate attributes a price of 16.13 euros per share to the Biofrontera common shares. If this accurately represents the fair market value of the Biofrontera common stock, then DNAPrint's 455,179 shares of Biofrontera stock, which it acquired for 1.5 million euros in July 2005, would now be valued at approximately 7.3 million euros.
``We believe our investment in Biofrontera will prove to be beneficial to DNAPrint genomics and to our shareholders,'' said DNAPrint genomics President and Chief Executive Officer Richard Gabriel. ``It validates our decision to build a collaborative relationship with Biofrontera in advance of its anticipated initial public offering.''
``Biofrontera is an excellent business partner for us because of its drug-product pipeline,'' said Hector J. Gomez, Ph.D., Chairman and Chief Medical Officer at DNAPrint genomics. ``We are pleased with our relationship with Biofrontera, and we have the highest confidence in its management team. We are confident the new funding will assist Biofrontera in advancing its drugs into the market.''
Mr. Gabriel and Dr. Gomez both are members of Biofrontera's Board of Directors.
LOOKS BETTER THAN GREAT YAHOOOOO --- GEO
golf4uto ......
I found it ......
NICE upward trend ......
Tradeing at 106.00 Euros .....
now how many shares/bonds do we have of Biofontra? ......
GONNA DO THE MATH BRB --- GEO
golf4uto .....
I've been told ......
that these are signals .....
It may or not be true ......
so here it is ......
100 I need shares
200 I need shares bad but don't take it down
300 Take it down to get shares
400 Trade it sideways based on demand
500 Gap one way or the other usually in the direction of the 500 trade
600 ????
YOUR WELCOME --- GEO
As posted by Cosmiclifeform .....Excellent Read ...
and not includeing the M/A of Kennan ......
as well as the ADD advantage DNAP is working towards ....
DNAPrint Genomics - PRODUCT PIPELINE – September 2005
MILESTONES FOR FORENSICS AND CONSUMER MARKETS
ANCESTRYbyDNA 2.0….R/D 2000-01… 4Q 2002 market… Mar2004*replaced w/ V2.5
ANCESTRYbyDNA 2.5….R/D 2003….Feb2004 market….Feb2005 Laptop Biochip System
ANCESTRYbyDNA 3.0…...R/D 2005………2006 market?
EURO-DNA 1.0…………R/D 2003……….......4Q 2004 market
DNAWitness 2.0….R/D 2002…………….2003 market……...2004*replaced w/ V2.5
DNAWitness 2.5 …R/D 2003...July 2004 market…Test kit - late 2005 ...global sales 2006
DNAWitness 3.0…………………R/D 2005 (3.0 to include eye color)
EURO Witness 1.0…………R/D 2004………….Feb2005 market
RETINOME 1.0 Eyecolor. …R/D 2003....4Q 2004 market…Test kit - late 2005…global sales 2006
RETINOME HA Haircolor…….R/D 2004….2005-06 validate…..2007 beta test……..2008 market?
SKIN SHADE………………………………….R/D 2005-07……2008 market?
AMERIND 1.0…………………………………R/D 2005-06……2007 market?
Genetic Family Tree DB……………R/D 2004………….online 2005
Searchable Ancestry Genealogy DB…………...R/D 2003……online 2004………expand 2005
Searchable PhotoAncestryDB (Forensics)……R/D 2003……..online 2004………..expand 2005
DNA Database for Native Americans…develop 2003/2004….expand 2005
DNA Database for African-Americans….develop 2005
* NEW– Forensics – 3D BIOMETRICS Imaging System for fuzzy photo………Jun 2005 develop
* NEW DNAG ACQUISITION – Trace Genetics – leaders in genealogy, forensics, and molecular diagnostics ……..Acquired Jun 2005
MILESTONES FOR PHARMACOGENOMICS AND THERANOSTICS
Drugs and Predictive Drug Classifier Test Combinations
1) Ovanome - Taxol/Carboplatin efficacy
* R/D 1998…Announce Mar 2000…Validation Studies 2002-2004…Clinical Study May 2005…FDA late 2006….
2) Statinome - Lipitor, Zocor, efficacy, liver, muscle adverse myalgia response
* R/D 1998….Clinical Studies late 2004/early 2005…FDA 2007?...Market?...
3) Acenome - Enalapril, Lisinopril efficacy, muscle, adverse cough
* R/D 1998….Clinical Studies late 2004/early 2005…FDA 2007?...Market?...
4) BC-LOH – Breast Cancer (DNAG/Moffitt)
* R/D 2003…………………Clinical Studies 2005/2006…..FDA 2007-8?...Market?
5) Ondansetron – Chemo-nausea (DNAG/Moffitt)
* R/D 2003…………………Clinical Studies 2005/2006…..FDA 2007-8?...Market?
6) Melphalan/Topotecan – Multiple Myeloma (DNAG/Moffitt)
* R/D 2003…………………Clinical Studies 2005/2006…..FDA 2007-8?...Market?
7) Xeliri/Xelox – Colon Cancer (DNAG/Moffitt)
* R/D 2003…………………Clinical Studies 2005/2006…..FDA 2007-8?...Market?
8) Immunosuppressants - Sirolimus, Tacrolimus, Mycophenolate
* R/D 2001…NYU Open R/D?….
9) Acute Lymphocyte Leukemia (ALL)
* R/D 2005…Joint Publication late 2005….DNA Screening Test 2006?…..
10) Cervical Cancer and Environmental Tobacco Smoke
* FAMRI Grant Feb 2003….2 year grant….Publication 2006?....
11) Super EPO Anemia Drug
* License Apr 2005…Pre-clinical 4thQ 2005/2006…FDA IND late 2006/early 2007….
* DNAG exclusive worldwide license to develop a Super EPO drug with a $10 billion dollar market potential.
* NEW - Jun 2005
– Consulting contract with inventor/patent-holder to help DNAG develop super EPO drug
– Contract for CRO to manufacture super EPO drug for pre-clinical testing, ready Fall 2005
* Latest News – Another New Acquisition (July 13, 2005)
DNAPrint Genomics Acquires 18% Interest In Biofrontera, A Small German Pharmaceutical Company With 3 Drugs Already In Pipeline
Biofrontera’s Drug Pipeline (now Biofrontera/DNAG) :
12) BF-Derm1 - for antihistamine-refractory urticaria – in Clinical Phase II Trials….2006/2007 market
13) 5-aminolevulinic acid (ALA) - for actinic keratosis – in Clinical Phase II Trails….2007/2008 market
14) 5-HT2B receptor antagonist - for migraine prophylaxis - in Preclinical Development…2010 market
* Biofrontera milestone note: Biofrontera stated its intentions to do an IPO stock offering in Europe within 9 months, which of course if it happens, it will bring additional value to DNAG investors.
* NEW – September 6, 2005 - Biofrontera completes bond funding for $20million euro. IPO stock offering for Biofrontera on track.
.
** Not yet included on this pipeline list are possible defense contracts DNAG is currently working on to get.
UP UP and AWAY --- GEO
Objectively ......
Times are changeing .......
the public is demanding "safer-drugs" ......
Baby Boomers are getting older ......
Big Pharma is poised to profit ......
Genomics is poised to profit .......
PLACE YOUR BETS --- GEO
ann & gratli ....
I glad you got a chuckle ......
imagine no perfct man? ....
LOL --- GEO
OT: Just for laughs ....
Can you figure it out? .....
Becareful ......
http://www.flashfunpages.com/couple.swf
HOPE IT MADE YOU SMILE --- GEO
Just a thought ......
What if Pfizer ......
or Merck ......
or Johnson & Johnson .....
or Roche ....
or Biofantra ......
or any Pharma group .....
said it joint ventured with a Co. .......
in order to pursue "safer-drugs" for the public ......
I think I know .....
Public Opinion would swing their way ......
and their SP would rise ......
AND WE WOULD BE HOLDING OUR NUTS --- GEO
Gratli ......
Excellent News today ......
I am Glad that DNAG .......
has allowed us as Share Holders .....
to understand their stategy, going forward .....
I ask myself if it could work? .......
could they actually help in the area of "safer medicine"? ....
and I think they can .......
They have 6 yrs of research ......
any Pharma group could "fall back" on this research .......
and produce "new & improved" medicines for market .......
The "public" is starting to see the need for this ......
and with the "one size fits all" mentality .......
its starting to look like that thought process doesn't ......
work all that well now ......
I think the public use to think that a medication ......
would work the same on everyone .....
and are starting to understand that it doesn't ........
"Public Demand" will be our greatest ally ........
Education of "safer drugs" is all it will take .....
todays News allows us as Share Holders ......
to understand that "extra step" DNAG has taken ......
towards personal medicine .....
Now if we as a Long term investor ......
Could Hold and buy the deals ......
in other words "wait for the dump" ......
we could accumulate at great prices ......
there are a lot more long term investors here ......
than the "fellows" who insist on driveing the price down ....
so wait for them to move and grab what you can ......
do not make it easy for them ......
they are penny stock terrorists ........
and understanding them ......
is the way to "beat" them ......
Move up slowly, it will drive them nuts ......
and speaking of nuts .....
did I ever tell you the fable of the Squirrel? .....LOL
HOLD AND BUY THE DEALS --- GEO
All in All ......
"Simply put, DNAPrint will utilize computational modeling to develop drugs more efficiently," said DNAPrint President and Chief Executive Officer Richard Gabriel. "It will play a valuable role in any company's efforts to pursue the development of drugs which maximize efficacy and minimize side effects by tailoring medications for specific individuals and well-defined population sectors."
Excellent News today ......
It will take only "one" deal ........
to understand the importants of this NR .......
Maximizing efficacy and Minimizing side effects ......
could be a great Co. builder .......
Joint Ventures with many Companys .......
Would well serve us as Share Holders .......
We have everything we need .......
We have the Experts ........
We have the Labs ........
We have the Technology ........
JMHO, DNAG will do the R/D for some Pharma groups .......
with a % of revenue generated ........
on the "new" drug .........
LIFE IS GOOD --- GEO
80spitfire ......
They are "penny stock" terrorists ......
They probably have more shares ......
put together, than the rest of us ......
waiting for them to dump ......
would be a good Idea .......
play their game ......
Dnag seems to be putting ......
all the pieces in the right place .......
a bigger "engine" ......
can improve performance ......
HOLD & BUY THE DEALS --- GEO
If you are Long Term ......
Then you should .....
LOCK & LOAD --- GEO ( but don't chase )
Why does a squirrel .......
gather nuts in the summer? ......
because ......
HE/SHE KNOWS WINTER IS COMEING --- GEO
DNAG .....
Will try to perform CPR ........
On "lost" drugs ......
as well as "fast tracking" new ones ..........
imagine the "time and money" saved ..........
by anyone interested .............
EXCELLENT NEWS --- GEO
NEWS OUT ......
EB and COSMIC .......
YOU NAILED IT ON THE HEAD --- GEO
Snap Hook ....
Thats Right .....
Bigger Bang for their Buck ....
It would only make sense .....
even for the houses .......
WOULDN'T IT? --- GEO
aries4747 ....
You're right .....
sorry I didn't mean to mislead anyone ......
HUMBLED --- GEO
DOC_OC ........
That means 8mil more .....
than 2 weeks ago .......
NOT BAD --- GEO
I went over to the RB .....
and you can sure tell who sold today .......
it's kinda funny .......
I don't like to go there ......
but today ......
I thought I'd get a few chuckles .....
DNAG IS A WINNER AND DON'T LET THEM TELL YOU OTHERWISE --- GEO
smiley .....
10k out soon .....
I think we will see .....
WHAT ALL THE VOL IS ABOUT JMHO --- GEO
hopeless .....
you ask ME where is your money? ......
I hope for you ......
its in DNAG .....
HOLD AND BUY THE DEALS --- GEO
Like shakeing a tree ......
a little early morning pruning .....
WHAT WILL THE REST OF THE DAY BRING --- GEO
Hopeless ....
I will give you ......
A RED ONE --- GEO
Hopeless107 ......
I'm holding you accountable .......
for my coffee stain shirt .......
I "blew" coffee out my nose and nearly choked to death ......
on your last post .......
I expect you will pay to remove the stain? ........
YOU ARE A FUNNY SORT OF FELLOW --- GEO
Hopeless107 .....
Even Better yet .....
I BET we stay ......
above todays opening by weeks end .........
$50.00 --- GEO
Hopefull107 .....
better yet.....
I bet you $50.00 we go up today .......
BET,BET,BET,BET,BET --- GEO
anotherday .....
I WOULD SAY POSITIVE --- GEO
Not to sound like a broken record ....but
HOLD and BUY THE DEALS (if you can) --- GEO
stinkboy .....
you should have averaged down after the R/S ......
you could have had a far lesser Break even point ......
THAN YOU DO NOW --- GEO
Ok Chris ......
Before I would listen to Jevers predictions, I would better off looking into a snow globe for the future (like a crystal ball), So I did and the snow globe predicted it was going to snow. My point being ..... DNAG has way to much on the go not to have more positive NR in the future.
Jevers predictions are like a snow globe, you know the out come if you shake it.Jever is hopeing DNAG will be shaken every week, and while I'm on it: his last prediction next week will be " NEWS FRIDAY"; But I wish Jever would not say anything until after a NR.
PHARMA - KARMA --- GEO
Chris .......
before I acted on Jevers predictions ......
I would look ......
deeply into ......
a snow globe .......
for the future .......
so I did ......
and it told me, in a vision that ........
IT'S GOING TO SNOW --- GEO
DNAG .....
Their Staff are PROs .........
Their M&A has been outstanding .......
Their DNAWITNESS is the best in the World ........
Do not forget they went to the forensic conference ......
in late Aug ......
Forensics is a $500,000,000 industry in the U.S .....
DNAWITNESS is involved in the Innocence Project .......
DNAWITNESS is JMHO will be the bench mark for DNA testing .....
WORLD WIDE --- GEO
Dr Fud ......
You might be right ......
or ......
you might be wrong ......
I'M BETTING AGAINST YOU --- GEO
P.S A RESPONSE IS NOT IMPLIED
Tomorrow .....
Should be an interesting day ......
WHAT ARE YOU THINKING --- GEO